NCT00327587

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

An 8-week, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Valsartan/HCTZ/Amlodipine Compared to Valsartan/HCTZ, Valsartan/Amlodipine, and HCTZ/Amlodipine in Patients With Moderate to Severe Hypertension.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 2,279 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine the safety and efficacy of the various combinations of valsartan, HCTZ, and amlodipine in patients with moderate to severe hypertension.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Valsartan + amlodipine
DRUG	Valsartan + HCTZ
DRUG	Amlodipine + HCTZ
DRUG	Valsartan + amlodipine + HCTZ

Timeline

• Start date: 2006-05-01
• Primary completion: 2007-08-01
• Completion: 2007-08-01
• First posted: 2006-05-18
• Last updated: 2011-11-08

Locations

1 site across 1 country: United States